BioCentury-BayHelix East-West Summit 2022 Details

BioCentury and BayHelix invite you to Register Now to join us at the East-West Summit BioPharma Summit at the Grand Bay Hotel San Francisco, Redwood City, CA on Nov. 14-16, 2022*.

For almost a decade, BioCentury and BayHelix and our partners have brought together a global community of C-suite executives and investors focused on biopharma innovation and cross-border collaboration. But the world has changed: Emerging biopharmas in the U.S., Europe and Asia now face the same dilemma: How do you globalize to deliver innovation to patients and achieve an ROI for investors?

  • A handful of biopharma companies will build global operations.
  • Most will achieve global economics through partnering and licensing.
  • Others will capture a share of the economics by enabling global development and financing.
  • And all will require trusted cross-border relationships for success.

The East-West Biopharma Summit is designed to help biopharma decision makers and investors rise to the Challenges of Globalization, understand globalization strategies and form trusted cross-border relationships.

Topics include:

  • Recruiting and retaining diverse cross-border management teams.
  • Accessing world-class investors in the U.S., Europe, and Asia.
  • Building and financing a MRCT (multiregional clinical trial) strategy.
  • Navigating regulatory sea changes in the U.S., Europe, and Asia.
  • Choosing between partnering and M&A to globalize product development and commercialization.
  • Deciding whether or when a physical presence is required overseas.

And much more….

Join us for:

  • Two days of strategic sessions to help busy executives understand successful globalization strategies.
  • C-level networking: Build relationships with biopharma decision-makers and investors in an intimate setting.
  • Four days of 1x1 meetings: Two days in person; two days virtual.
  • Road Show presentations from rising biotechs in the East and West, selected by BioCentury.
  • Digital option: Attend in-person or virtually via digital platform.
  • Prep in Advance: Use BioCentury's BCIQ platform to research data (pipelines, financings, deals) and BioCentury analysis to help prepare for your 1x1 meetings.

*Digital passes also available.

BioCentury-BayHelix East-West Summit At-A-Glance

Organizing Committee

Chair: Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Guo-Liang Yu, Ph.D.
Chairman & CEO, Apollomics Inc. and
Chairman, BayHelix
Debra Yu, M.D.
President & Chief Strategy Officer
LianBio
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Tony Chen
Partner
Jones Day
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Franck Le Deu
Senior Partner & Head of Greater China Healthcare Practice
McKinsey & Co.
Moreright-arrow

Sponsors

Moreright-arrow
Sponsorship opportunities availableSpeak with a BioCentury representative today

Presenting Companies

Moreright-arrow

2022 Presenting CompaniesJoin the BioCentury-BayHelix Presenting Company Class of 2022.

Testimonials

“The healthcare industry has seen a wave of innovation and development since the COVID-19 pandemic. The new era, that comes with uncertainties and macroeconomic headwinds, requires CEOs, entrepreneurs, and all to communicate effectively and embrace innovation. BioCentury and BayHelix put together a high-quality program that really captures the latest industry trends and offers a valuable opportunity to connect with thought leaders in the region. We look forward to continuing to support the BioCentury-BayHelix China Healthcare Summit, as we have in the past, and sharing our insights at the event.”

Nisa Leung
Managing Partner
Qiming Venture Partners

"The BioCentury & BayHelix China Healthcare Summit has grown from strength to strength over the last eight years. It has become the reference China event for the biopharma community, with an increasingly global audience. As McKinsey, we are proud of our contribution to the Summit as Insights Partner, with our series of reports on “Building Bridges to Innovation”. We look forward to the ninth edition of the event. Given the current context around biotech and the biopharma industry, we expect the event to be once again a great gathering of minds to crystalize trends and shape the journey together."

Franck Le Deu
Senior Partner & Head of Greater China Healthcare Practice
McKinsey & Co.